Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study.
Forde C, Smith MJ, Burghel GJ, Bowers N, Roberts N, Lavin T, Halliday J, King AT, Rutherford S, Pathmanaban ON, Lloyd S, Freeman S, Halliday D, Parry A, Axon P, Buttimore J, Afridi S, Obholzer R, Laitt R, Thomas O, Stivaros SM, Vassallo G, Evans DG. Forde C, et al. Among authors: buttimore j. J Med Genet. 2024 Aug 29;61(9):856-860. doi: 10.1136/jmg-2024-110065. J Med Genet. 2024. PMID: 38925914
Cochlear Implantation in Neurofibromatosis Type 2: Experience From the UK Neurofibromatosis Type 2 Service.
Smith ME, Edmiston R, Trudel M, Freeman S, Stapleton E, Axon P, Donnelly N, Tysome JR, Bance M, Obholzer R, Jiang D, Mackeith S, Ramsden J, O'Driscoll M, Mawman D, Buttimore J, Nunn T, Humphries J, Evans DG, Lloyd SKW; UK NF2 Research Collaborative. Smith ME, et al. Among authors: buttimore j. Otol Neurotol. 2022 Jun 1;43(5):538-546. doi: 10.1097/MAO.0000000000003507. Epub 2022 Feb 24. Otol Neurotol. 2022. PMID: 35213477
Evidence-based surveillance protocol for vestibular schwannomas: a long-term analysis of tumor growth using conditional probability.
Borsetto D, Sethi M, Clarkson K, Obholzer R, Thomas N, Maratos E, Barazi SA, Baig Mirza A, Okasha M, Danesi G, Pusateri A, Bivona R, Ferri GG, El Alouani J, Castellucci A, Rutherford S, Lloyd S, Anwar B, Polesel J, Buttimore J, Gamazo N, Mannion R, Tysome JR, Bance M, Axon P, Donnelly N. Borsetto D, et al. Among authors: buttimore j. J Neurosurg. 2022 Feb 18;137(4):1026-1033. doi: 10.3171/2022.1.JNS211544. Print 2022 Oct 1. J Neurosurg. 2022. PMID: 35180698
Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression.
Evans DG, Halliday D, Obholzer R, Afridi S, Forde C, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SM, Pathmanaban ON, Thomas OM, Laitt RD, Stivaros S, Kilday JP, Vassallo G, McBain C, Lavin T, Paterson C, Whitfield G, McCabe MG, Axon PR, Halliday J, Mackeith S, Parry A; English Specialist NF2 Research Group; Harkness EF, Buttimore J, King AT. Evans DG, et al. Among authors: buttimore j. Neurooncol Adv. 2023 Mar 11;5(1):vdad025. doi: 10.1093/noajnl/vdad025. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37051330 Free PMC article.